Higher CASC2 expression causes slight up-regulation in the survival of patients with hepatocellular carcinoma (Fig.S4C); lower miR-24 and miR-221 expression is significantly correlated with longer survival of patients with hepatocellular carcinoma (Fig.S4D-E). The gene discussed is CASC2; the disease is hepatocellular carcinoma.